China Tian Yuan Healthcare : CLARIFICATION ANNOUNCEMENT

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA TIAN YUAN HEALTHCARE GROUP LIMITED

中國天元醫療集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 557)

CLARIFICATION ANNOUNCEMENT

Reference is made to the announcement of China Tian Yuan Healthcare Group Limited (the"Company"), dated 21 April 2021 (the "Announcement") in relation to change of date of board meeting. Unless otherwise defined, capitalised terms used in this announcement shall have the same meaning as those defined in the Announcement.

The Board would like to clarify the information as below:

The Board hereby announces that as the Company requires additional time to collate the information and documents of the subsidiaries required to address the request by the Company's external auditor, Crowe (HK) CPA Limited to finalise the audit work of the 2020 Annual Results, the date of board meeting will be further announced.

The clarifications contained in this announcement do not materially affect other information contained in the Announcement. Save as disclosed above, all other content in the Announcement shall remain unchanged.

CONTINUED SUSPENSION OF TRADING

At the request of the Company, trading in the shares of the Company on the Stock Exchange was suspended with effect from 9:00 a.m. on Monday, 24 August 2020 and will remain suspended until further notice.

Shareholders of the Company and potential investors are advised to exercise caution when dealing in the shares of the Company.

By Order of the Board

China Tian Yuan Healthcare Group Limited

Zhang Xian

Executive Director

Hong Kong, 22 April 2021

As at the date of this announcement, the Board is composed of seven directors of which Mr. Wang Huabing (chairman) and Ms. Zhang Xian are the executive directors, Ms. He Mei and Mr. Zhou Yuan are the non-executive directors and Mr. Hu Baihe, Mr. Yuen Kwok Kuen and Mr. Guo Jingbin are the independent non-executive directors.